BLTE Q2 2025 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena

BLTEBelite Bio, Inc

$7B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$18M

Net Income

-$16M

EPS (Diluted)

$-0.50

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$156M

Total Liabilities

$7M

Stockholders' Equity

$150M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$18M	-$10M	-68.0%
Net Income	-$16M	-$9M	-71.9%